<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DA82066A-2B1B-412F-8D72-43273A319CA6"><gtr:id>DA82066A-2B1B-412F-8D72-43273A319CA6</gtr:id><gtr:name>Roche</gtr:name><gtr:address><gtr:line1>PRG Building 93 room 6 10</gtr:line1><gtr:line2>F Hoffman La Roche</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCE508CA-70B7-43EC-99A2-3197E0AA3077"><gtr:id>DCE508CA-70B7-43EC-99A2-3197E0AA3077</gtr:id><gtr:name>Ono Pharmaceutical</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/680A2524-B8AD-4E19-ACD2-3EECFCC5DAF1"><gtr:id>680A2524-B8AD-4E19-ACD2-3EECFCC5DAF1</gtr:id><gtr:name>Hull York Medical School</gtr:name><gtr:address><gtr:line1>John Hughlings Jackson Building</gtr:line1><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DA82066A-2B1B-412F-8D72-43273A319CA6"><gtr:id>DA82066A-2B1B-412F-8D72-43273A319CA6</gtr:id><gtr:name>Roche</gtr:name><gtr:address><gtr:line1>PRG Building 93 room 6 10</gtr:line1><gtr:line2>F Hoffman La Roche</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCE508CA-70B7-43EC-99A2-3197E0AA3077"><gtr:id>DCE508CA-70B7-43EC-99A2-3197E0AA3077</gtr:id><gtr:name>Ono Pharmaceutical</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/680A2524-B8AD-4E19-ACD2-3EECFCC5DAF1"><gtr:id>680A2524-B8AD-4E19-ACD2-3EECFCC5DAF1</gtr:id><gtr:name>Hull York Medical School</gtr:name><gtr:address><gtr:line1>John Hughlings Jackson Building</gtr:line1><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BDA78D1E-1BC3-45B7-AD4E-D0BEF05B9980"><gtr:id>BDA78D1E-1BC3-45B7-AD4E-D0BEF05B9980</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:otherNames>Gabriela</gtr:otherNames><gtr:surname>Belvisi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D6F9C5EC-5B35-4D55-BF48-E9A4BB2DA979"><gtr:id>D6F9C5EC-5B35-4D55-BF48-E9A4BB2DA979</gtr:id><gtr:firstName>Deborah</gtr:firstName><gtr:otherNames>Lee</gtr:otherNames><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800195"><gtr:id>3CE933FC-E62C-4208-A12D-758E1F6B2464</gtr:id><gtr:title>Prostanoid receptors as targets for asthma and COPD therapy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800195</gtr:grantReference><gtr:abstractText>Asthma is an inflammatory disease of the lung that affects a large percentage of the population in the Western world and represents a huge health care burden and is characterised by chest tightness and breathing difficulties. There are 5.2 million asthma sufferers in the UK, 1.1 million children (1 in 10) and 4.1 million adults (1 in 12). On average, 1400 people die from asthma each year, and asthma now costs the NHS an average of #889 million per year. The Global Burden of Disease studies ranked COPD as the 6th commonest cause of death worldwide in 1990 and this has now risen to 4th. In the UK COPD now causes about 30,000 deaths a year and mortality is almost double the European average, with COPD killing more women than breast cancer last year.Inflammation is believed to be central to the development and symptoms of asthma and COPD. A naturally occurring chemical in the body can open the airways and reduce the inflammation through interactions with one or more of a family of proteins. Unfortunately, this chemical also causes cough. The aim of this study is to try to determine which of the proteins are involved in the beneficial responses and which in the detrimental cough response of the chemical. The hope is that this work may lead to the discovery of a novel drug which could selectively target the beneficial processes leading to the production of a therapy that could help these patients who suffer from these debilitating diseases.</gtr:abstractText><gtr:technicalSummary>In the clinic, patients with asthma and COPD are treated with either beta-agonists to induce bronchodilatation, or steroids to control the underlying airway inflammation observed in this disease. The prostanoid, PGE2 has been reported to induce bronchodilatation in animals and humans, and confers certain advantages over existing bronchodilators due to its anti-inflammatory potential. However, PGE2 also causes airway irritancy and cough. Prostanoids act at G-protein coupled receptors, of which five main classes have been identified. The EP-receptor also exists in four subtypes. PGE2 relaxes smooth muscle (possibly via activation of the EP2 receptor) and is anti-inflammatory (receptor not known). Furthermore, the receptor that induces cough has not been characterised. It is, therefore, possible that the EP-receptor subtype mediating irritancy and cough differs from that mediating bronchodilatation and anti-inflammatory effects. The current proposal aims to classify the receptor(s) through which prostanoids act to stimulate airway vagal sensory nerves, nerves that are instrumental in orchestrating the cough reflex. In addition, we also aim to investigate the receptors involved in evoking the anti-inflammatory effects attributed to prostanoids under both normal and disease conditions. This work may highlight a bronchodilator and anti-inflammatory agonist devoid of side-effects that may be formulated as an anti-asthma/COPD therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>587716</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hull York Medical School</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration - Hull</gtr:description><gtr:id>808FC734-A031-4357-B3B3-AF9212A685C6</gtr:id><gtr:impact>PMID: 19818366</gtr:impact><gtr:partnerContribution>A collaborative study was initiated and as part of this a clinical study was undertaken in Hull to evaluate the tussive potential of an environmental challenge agent.</gtr:partnerContribution><gtr:piContribution>We contributed by providing a major intellectual contribution in the developing the project hypothesis, desigining and performing the majority of the pre-clinical studies. We also wrote the paper which was accepted by the American Journal of Respiratory and Critical Care Medicine (highest IF respiratory journal)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>Collaboration - Manchester</gtr:description><gtr:id>5F5B067F-49B7-47F0-96CE-70A536A0C24B</gtr:id><gtr:impact>Ethical approval is in place and the clinical study has been completed. Abstract to be presented at ATS, BPS and BTS 2011/12.</gtr:impact><gtr:partnerContribution>Provided clinical expertise in follow up studies.</gtr:partnerContribution><gtr:piContribution>Based on this research we have formed a collaboration to carry out a clinical study to evaluate the tussive potential of Prostaglandin E2 in normal volunteers and in patients with asthma, COPD, smokers and idiopathic cough.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ono Pharmaceutical</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>ONO pharamcological tools</gtr:description><gtr:id>699FB24E-84CB-4D48-B5E5-2E0668E8ACE0</gtr:id><gtr:impact>Obtaining these compounds and prostanoid receptor knockout mice enabled us to write a successful grant application to fund this project and has resulted in the publication of several abstracts, a journal article (PMID: 19729667) and review articles (PMID: 19830488 and PMID: 19818366)</gtr:impact><gtr:partnerContribution>ONO pharmaceuticals provided pharmacological agonists and antagonists to support our research and genetically modified mice</gtr:partnerContribution><gtr:piContribution>We performed all the experiments that contributed to a subsequent publication.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck &amp; Co. Inc. (MSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Merck pharmacological tools</gtr:description><gtr:id>7E61F291-872C-4BC1-AFFE-C85CD019FAF3</gtr:id><gtr:impact>These compounds have resulted in the publication of several abstracts, a journal article (PMID: 19729667) and a review (PMID: 19830488, PMID: 19818366)</gtr:impact><gtr:partnerContribution>Merck supplied a selective EP3 antagonist L826266 and also analysed some samples from our in vivo study</gtr:partnerContribution><gtr:piContribution>We performed the in vitro and in vivo experiments carried out with this compound that contributed to the subsequent publications</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK pharmacological tools</gtr:description><gtr:id>E71E66DA-E53E-419F-A36C-6CF6E03326E3</gtr:id><gtr:impact>These compounds have resulted in the publication of several abstracts, a journal article (PMID: 19729667) and a review (PMID: 19830488, PMID: 19818366)</gtr:impact><gtr:partnerContribution>GSK provided selective agonists and antagonists</gtr:partnerContribution><gtr:piContribution>We performed all the experiments that contributed to subsequent publications.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Roche</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Roche pharmacological tools</gtr:description><gtr:id>EBC4CA7E-5EF8-41C2-9BE1-2C6C761BB83A</gtr:id><gtr:impact>The availablilty of this compound has resulted in the publication of several abstracts, a journal article (PMID: 19729667) and a review (PMID: 19830488 and PMID: 19818366 )</gtr:impact><gtr:partnerContribution>Roche provided a selective IP antagonist for use in these studies</gtr:partnerContribution><gtr:piContribution>We performed all the experiments that contributed to subsequent publications.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Britiah Pharmacological Society youtube</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A126AE39-7A8B-4BEB-BBEA-820615098509</gtr:id><gtr:impact>One of our PhD students filmed a veideo about how LABA's work in asthmatics as part of a series 'How do drugs work' for the British Pharmacological Society.

Additional invitations to participate in media and outreach events</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=j-EOGJECjXY</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> HEFCE Medical Sciences Summer School</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B24FB177-BE80-4A8E-AF90-D2AD8F16465A</gtr:id><gtr:impact>Chance to debate isues around the use of animals in research

Excellent feedback from schools that took part</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FFE3BA9E-305A-4B6E-B0E6-F7B0F493B768</gtr:id><gtr:impact>We wrote a press release, in collaboration with Imperial College Press office following the publication that the TRPA1 is involved in the cough response to environmental irritants (PMID: 19729665).

The press release was published in several different websites and newspapers (including the MRC website, Daily Mail). Links to these are shown below. We also had over 10 patients contact us by telephone for advice following this breakthrough. http://www.mrc.ac.uk/Newspublications/News/MRC006506 http://www.dailymail.co.uk/health/article-1230125/A-cure-coughing-offing.html http://www.dailyindia.com/show/346080.php http://www.news-medical.net/news/20091124/Scientists-identify-factors-behind-chronic-coughing.aspx http://www.medicalnewstoday.com/articles/172027.php http://www.sciencedaily.com/releases/2009/11/091123094126.htm?utm_source=feedburner&amp;amp;utm_medium=feed&amp;amp;utm_campaign=Feed%3A+sciencedaily+(ScienceDaily%3A+Latest+Science+News) http://www.sflorg.com/comm_center/unv_medical/p951_231.html</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-1230125/</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release 2</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A2EE5A83-391C-4E48-9F74-6321651DDB3E</gtr:id><gtr:impact>Our data regarding the role of reflexes in the late asthmatic response following allergen challenge has been published (and was highlighted by the media (21841185) (http://www.bbc.co.uk/news/health-14504186).

Invitations to discuss the research with various pharma companies.
Inclusion in WP6 of the Severe asthma IMI initiative.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-14504186</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang Fair</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3414B6E5-B31B-4522-B4A6-D8AC3843B8BE</gtr:id><gtr:impact>Demonstrating experiments to the public on a stand.

The same person was asked to oparticipate in other events</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Involvement (Manchester)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>186C0DC7-EFCC-4847-8B06-C4086CB66356</gtr:id><gtr:impact>Out clinical collaborators (MRC grant partners on this award) in Manchester hold an event each year to keep chronic cough patients up to date with the work they are doing in their clinic and through our research to find a cure for chronic cough. Combat my Cough is an opportunity to listen to and talk to the research team, but also for you to meet and talk to other sufferers with the condition.

 http://www.combatmycough.com/#!events/c1k9b</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.combatmycough.com/#!events/c1k9b</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture for Trainees (Meidcal, BSc, PhD, Nurses, University Hospital of South Manchester)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B3E171C2-63A9-49F3-A58A-80C0707A0CAE</gtr:id><gtr:impact>More than 150 nurses, clinicians, BSc, PhD students, patients, pharma attended. I gave a plenary talk and judged a young scientist prize.
Respiratory Forum, University of South Manchester, Wythenshawe, 10th October 2012.

The conference was successful and will run again next year. Evaluation sheets distributed at the meeting established that the audience felt that the activity was worthwhile.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the Dana Centre (Science Museum Outreach Centre)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>49429341-90AD-46B7-B2F8-3B279AAF834E</gtr:id><gtr:impact>The lay public were allowed to ask the panel any questions regarding asthma, its disgnosis, treatment and research efforts in this area.

This event has sparked other public engagment events.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.danacentre.org.uk/events/2010/11/19/598</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>663782</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MICA-Investigation into the Mechanisms that drive Cough in Health and Disease</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DA7B81D7-82B6-409B-AF76-1745CC89C997</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC DTP Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>DDCA214C-5590-414A-93AA-07CFF9465EA7</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>365541</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Effect of theophylline on sensory nerve activity and the cough reflex: novel anti-tussive therapy)</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>089301/Z/09/Z</gtr:fundingRef><gtr:id>78D2E05E-EB23-4FCB-A0FB-C20E791E731C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC studentship obtained with the Integrative Mammalian physiol/pharmacol centre</gtr:description><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>3464AAEC-C1A4-4120-B00A-4B0BBA09180F</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>64B15CD3-6714-4370-A268-5A7F1D888293</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>409991</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of TRP receptors in various immune responses/airway disease</gtr:description><gtr:fundingOrg>Roche</gtr:fundingOrg><gtr:id>6E934637-9E4F-4269-8EF9-69DA12C47F16</gtr:id><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC 3+1 MRes/PhD Student -Awarded to Centre Integrative Physiology/Pharmacology Centre</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>81610D7C-3115-4F91-9F80-43A91A6D2322</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ERS/BTS Cough Task Force</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>5F68A065-4137-4F66-BCE6-2E80506E61FD</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>These tissue based assays inform about mechanistic information regarding the control of human respiratory reflexes.</gtr:description><gtr:id>58AEAE32-537D-4406-AF08-1BED28081D1D</gtr:id><gtr:impact>These tissue based assays inform about mechanistic information regarding the control of human respiratory reflexes.
Allows clinicians to better interpret in vivo clinical trial data. Collaboration and joint publications with 2 cough clinicians.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Characterisation and assay development of human vagal nerve preparation as in vitro assay for cough</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/18695648</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Single fibre recordings. This method can be used to determine nerve impulse recordings from single fibres arising in the jugular and nodose ganglia and innervating the lung.</gtr:description><gtr:id>A6B050AD-75E2-47AA-82DD-8839CE4D4154</gtr:id><gtr:impact>This technology has been adpated and optimised from Johns Hopkins, USA and has now been set up for the first time in the UK.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Developed methodologies to record activity in single afferent units innervating the lung</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>IR Pharma</gtr:companyName><gtr:description>http://www.irpharma.co.uk/</gtr:description><gtr:id>D02E36CF-4515-4848-8632-A3B24543FBA0</gtr:id><gtr:impact>CRO in the pre clinical respiratory arena.
Enabled by the expertise and knowledge base within the Respiratory Pharmacology Group.
Funded in part by Imperial College Innovations</gtr:impact><gtr:url>http://www.irpharma.co.uk/</gtr:url><gtr:yearCompanyFormed>2010</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/117155BE-BEEB-478B-B78A-1E2D242A5979"><gtr:id>117155BE-BEEB-478B-B78A-1E2D242A5979</gtr:id><gtr:title>Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0349ed525e56a7f6dd74b0a76f194840"><gtr:id>0349ed525e56a7f6dd74b0a76f194840</gtr:id><gtr:otherNames>Bonvini SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36714A6E-7A61-429C-87D8-F832AC2185E4"><gtr:id>36714A6E-7A61-429C-87D8-F832AC2185E4</gtr:id><gtr:title>Prostanoids and the cough reflex.</gtr:title><gtr:parentPublicationTitle>Lung</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0341-2040</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C38C3835-C3EA-4116-B6B3-1DAAE0C75A4A"><gtr:id>C38C3835-C3EA-4116-B6B3-1DAAE0C75A4A</gtr:id><gtr:title>G-protein coupled receptors regulating cough.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44BF6121-F008-46DB-BA68-8A6597DB3AFF"><gtr:id>44BF6121-F008-46DB-BA68-8A6597DB3AFF</gtr:id><gtr:title>Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2B765AC-E658-4BD3-9878-D88678B52E88"><gtr:id>F2B765AC-E658-4BD3-9878-D88678B52E88</gtr:id><gtr:title>EP4 receptor as a new target for bronchodilator therapy.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35ed95dd227d373240e59c417dc003ae"><gtr:id>35ed95dd227d373240e59c417dc003ae</gtr:id><gtr:otherNames>Buckley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C058825-91F7-4739-84D0-3163673E8FE3"><gtr:id>0C058825-91F7-4739-84D0-3163673E8FE3</gtr:id><gtr:title>Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05080bb9b45fef1e8ba299421900805d"><gtr:id>05080bb9b45fef1e8ba299421900805d</gtr:id><gtr:otherNames>Jones VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/088AC34E-9CE0-4E80-8A0B-19059EB5806A"><gtr:id>088AC34E-9CE0-4E80-8A0B-19059EB5806A</gtr:id><gtr:title>Transient receptor potential A1 channels: insights into cough and airway inflammatory disease.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4D0604D-47E1-4B77-9EB0-B4C01964531D"><gtr:id>E4D0604D-47E1-4B77-9EB0-B4C01964531D</gtr:id><gtr:title>A role for sensory nerves in the late asthmatic response.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b55a51605949dd812ca5f0f589b7cd6a"><gtr:id>b55a51605949dd812ca5f0f589b7cd6a</gtr:id><gtr:otherNames>Raemdonck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9BC98C2-9036-4864-8512-F1D185BC1BE2"><gtr:id>E9BC98C2-9036-4864-8512-F1D185BC1BE2</gtr:id><gtr:title>Theophylline inhibits the cough reflex through a novel mechanism of action.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ca7bbf9d2f4641822911b446142a2085"><gtr:id>ca7bbf9d2f4641822911b446142a2085</gtr:id><gtr:otherNames>Dubuis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C381167C-D1D4-49A3-BA8F-65B4209124DC"><gtr:id>C381167C-D1D4-49A3-BA8F-65B4209124DC</gtr:id><gtr:title>Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64139B29-5536-4ADC-81B8-395BD7A03DC8"><gtr:id>64139B29-5536-4ADC-81B8-395BD7A03DC8</gtr:id><gtr:title>Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/409013ced707ef97e89d9fe80edc73a9"><gtr:id>409013ced707ef97e89d9fe80edc73a9</gtr:id><gtr:otherNames>Grace M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2AB8867-C034-4DCD-B900-1CD854572154"><gtr:id>F2AB8867-C034-4DCD-B900-1CD854572154</gtr:id><gtr:title>Pre-clinical studies in cough research: role of Transient Receptor Potential (TRP) channels.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68B9AFD4-EB2F-4201-8C71-AAACB5B5640F"><gtr:id>68B9AFD4-EB2F-4201-8C71-AAACB5B5640F</gtr:id><gtr:title>TRPA1 agonists evoke coughing in guinea pig and human volunteers.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B803FCC-7841-44EA-9837-B730539143BC"><gtr:id>4B803FCC-7841-44EA-9837-B730539143BC</gtr:id><gtr:title>TRP channel antagonists as potential antitussives.</gtr:title><gtr:parentPublicationTitle>Lung</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0341-2040</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/098A1D4B-36EC-4A01-88C5-09C669429FCB"><gtr:id>098A1D4B-36EC-4A01-88C5-09C669429FCB</gtr:id><gtr:title>Cigarette smoke induced airway inflammation is independent of NF-?B signalling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a4f302798b162e4c15f5946b501b744d"><gtr:id>a4f302798b162e4c15f5946b501b744d</gtr:id><gtr:otherNames>Rastrick JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6791893-67FA-43E2-BF4C-13FF6B6F041C"><gtr:id>D6791893-67FA-43E2-BF4C-13FF6B6F041C</gtr:id><gtr:title>Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AEF13C6-53A2-41CD-8887-330D7AEA541D"><gtr:id>2AEF13C6-53A2-41CD-8887-330D7AEA541D</gtr:id><gtr:title>TRPA1 receptors in cough.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94734A73-5BCE-4851-A52E-2E3E5C458921"><gtr:id>94734A73-5BCE-4851-A52E-2E3E5C458921</gtr:id><gtr:title>Bronchial epithelial cell-derived prostaglandin E2 dampens the reactivity of dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/472b5444d36c7e0c363f2f4b3f264d3c"><gtr:id>472b5444d36c7e0c363f2f4b3f264d3c</gtr:id><gtr:otherNames>Schmidt LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EB45BFF-F65D-463D-A419-11EC6B35BE44"><gtr:id>6EB45BFF-F65D-463D-A419-11EC6B35BE44</gtr:id><gtr:title>Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC0DFE0A-E52B-4A5F-AB6C-E75D15AD1093"><gtr:id>EC0DFE0A-E52B-4A5F-AB6C-E75D15AD1093</gtr:id><gtr:title>Role of transient receptor potential and pannexin channels in cigarette smoke-triggered ATP release in the lung.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86657e337abedb83adf26de5d8f16dcd"><gtr:id>86657e337abedb83adf26de5d8f16dcd</gtr:id><gtr:otherNames>Baxter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77E036CC-3588-4E26-9DD9-9C1B42CF9B73"><gtr:id>77E036CC-3588-4E26-9DD9-9C1B42CF9B73</gtr:id><gtr:title>Bronchodilator activity of bitter tastants in human tissue.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EDA9A910-B233-4FC1-8CF0-4A4FCC8E0E5E"><gtr:id>EDA9A910-B233-4FC1-8CF0-4A4FCC8E0E5E</gtr:id><gtr:title>Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b469f97f58077a1f59d1607710301f2"><gtr:id>9b469f97f58077a1f59d1607710301f2</gtr:id><gtr:otherNames>Nasra J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A78B2CDF-D437-427F-8739-B3099B19EB97"><gtr:id>A78B2CDF-D437-427F-8739-B3099B19EB97</gtr:id><gtr:title>TRPA1 is activated by direct addition of cysteine residues to the N-hydroxysuccinyl esters of acrylic and cinnamic acids.</gtr:title><gtr:parentPublicationTitle>Pharmacological research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59de09c266b4138abf61d785ba863130"><gtr:id>59de09c266b4138abf61d785ba863130</gtr:id><gtr:otherNames>Sadofsky LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-6618</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42B53694-F7B4-4879-8C06-835AE388F49D"><gtr:id>42B53694-F7B4-4879-8C06-835AE388F49D</gtr:id><gtr:title>Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/703F493F-4204-4530-BC4B-F4D0C141FDAC"><gtr:id>703F493F-4204-4530-BC4B-F4D0C141FDAC</gtr:id><gtr:title>Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800195</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>